SK Bioscience Co.,Ltd Logo

SK Bioscience Co.,Ltd

A global biotech firm developing vaccines for diseases like COVID-19, influenza, and shingles.

302440 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 310, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SK Bioscience is a global vaccine and biotechnology company dedicated to promoting human health through the research, development, and manufacturing of vaccines. Spun off from SK Chemicals in 2018, the company utilizes advanced platforms, including cell culture and recombinant protein technologies. Its portfolio of proprietary products includes SKYCovione™ (COVID-19), SKYCellflu® (the world's first cell-cultured quadrivalent influenza vaccine), SKY Zoster® (shingles), and SKY Varicella® (chickenpox). SK Bioscience actively expands its global presence through strategic collaborations with international partners and health organizations, such as the Bill & Melinda Gates Foundation, embodying its mission 'From Prevention To Cure'.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SK Bioscience Co.,Ltd and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등거래계획보고서
Korean 47.1 KB
2025-09-19 00:00
Related Party Transaction
특수관계인에대한부동산매도
Korean 5.2 KB
2025-09-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 92.4 KB
2025-08-29 00:00
Governance Information
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 7.9 KB

Automate Your Workflow. Get a real-time feed of all SK Bioscience Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SK Bioscience Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland LONN
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway LYTIX
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland MAB
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany N/A
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria MARI
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel MTLF
Median Diagnostics Inc. Logo
Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.
South Korea 233250
MediciNova,Inc. Logo
Developing small-molecule drugs for neurology, respiratory, and liver diseases.
Japan 4875

Talk to a Data Expert

Have a question? We'll get back to you promptly.